DHR

#103
Danaher Corporation
199.39 USD
+2.06%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
197.31
200.10
Jahresspanne
180.03
242.75
Tagesänderung
+2.06%
Monatliche Änderung
+5.39%
6 month change
-3.50%
Jahresänderung
+3.49%
Vorheriger Schlusskurs
195.36
Eröffnung
197.59
Bid
Ask
Tief
197.31
High
200.10
Volumen
1 385
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 141 B
  • Employee 60 K
  • Founded N/A
  • CEO Rainer M. Blair
  • Website www.danaher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BH3JF8
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
45.33
Preis-Umsatz-Verhältnis
6.67

Danaher Corporation

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

Nachrichten